Efficacy of Heptral® in the treatment of hepatic toxicity induced by cytostatic chemotherapy
The efficacy of Heptral® (ademethionine) was evaluated in the treatment of chemotherapy-induced hepatotoxicity in 19 patients with various malignancies. Four-week administration of oral Heptral® 400 mg twice daily was shown to reduce the level of transaminases to normal values in 10 of 12 patients w...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-08-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/230 |
Summary: | The efficacy of Heptral® (ademethionine) was evaluated in the treatment of chemotherapy-induced hepatotoxicity in 19 patients with various malignancies. Four-week administration of oral Heptral® 400 mg twice daily was shown to reduce the level of transaminases to normal values in 10 of 12 patients with grade 1 toxicity. Longer (2-to-4 month) use of Heptral® was required to normalize the level of transminases in grade 2 hepatotoxicity. The chemotherapy regimen was not changed during the use of this drug. |
---|---|
ISSN: | 1994-4098 1999-8627 |